Skip to content

DR. BART ROUSSARD

Active Private limited companyfounded 2002active for 24 yearsSchabbestraat 12, 3511 HasseltKBO/BCE: BE 0477.702.927

Lifetime

23 annual accounts with figures on one time axis, 24 filings since 2002
peak of €369,665 in 2022
€349,473▼ 4.8%
lowest -€83,381 in 2013
€213,442▼ 5.8%
peak of €926,305 in 2024
€866,625▼ 6.4%
€126,755▲ 63.2%
Board3 names since 2002
2 directors and 1 other
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Dividend €273,122Debts from €77,671 to €126,755

Key points

from the 2025 annual accounts

Equity

€866,625 ▼ 6.4%
926,3052024+213,442Profit-273,122Dividend866,6252025

DR. BART ROUSSARD paid out €273,122 in dividends. That is 128% of the 2025 profit.

Liquidity

5.94 was 14.74 in 2024

Short-term debts rose from €49,668 to €126,755.

Position in the sector

€866,625

More equity than 91% of companies in human health. The sector median is €125,188, over 21,387 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as DR. BART ROUSSARD has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,148 companies, not a prediction for DR. BART ROUSSARD. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 31-05-2002
Manager
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0477702927
Capital conversion · Amendment of the articles · Legal-form change · Resignations & appointments 100 shares · is in office as director, not named in the articles · is in office as director, not named in the articles · General meeting of 22-09-2023 · Gazette deed
reappointed as director General meeting of 13-12-2022 · Gazette deed
reappointed as manager appointed as manager · General meeting of 13-12-2016 · Gazette deed
All 38 events

Comparable companies

same main activity, similar in size and age
Company
DR. BART ROUSSARD Hasselt €1.0m €349,473 87.2% -
DOKTERS ROGGEN Diepenbeek €1.0m €319,110 85.9% -
Dr. Anne Aerts Sint-Truiden €1.1m €389,774 67.3% 3.4
DOKTER DE DYN JOHAN Lommel €1.0m €400,350 87.4% -
DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE Ypres €1.0m €354,014 92.7% -
DOCTEUR D.THIRY Mons €1.0m €347,290 83.2% -
CSP MEDICAL Namur €0.9m €362,203 60.3% -

These companies have the same main activity as DR. BART ROUSSARD: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €947,000 and €1.1m, founded between 2000 and 2004.

Official details

Source: KBO
Status
Active since 06-06-2002Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.301.673.3093511 Hasselt, since 19-01-2003
Financial year end
31 December
Peppol
Reachable since 31-10-2023
Company details

Annual accounts 2025

≈ €530,000estimated
€993,380▼ 1.1%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on DR. BART ROUSSARD

DR. BART ROUSSARD files the micro format. That format states no turnover. The gross margin rose from €115,467 in 2002 to €349,473 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. BART ROUSSARD

What is the company number of DR. BART ROUSSARD?
The company number of DR. BART ROUSSARD is 0477.702.927. The VAT number is the same number with BE in front: BE 0477.702.927.
Where is DR. BART ROUSSARD based?
The registered office is at Schabbestraat 12, 3511 Hasselt.Company details
What does DR. BART ROUSSARD do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. BART ROUSSARD?
DR. BART ROUSSARD is a private limited company (BV).
When was DR. BART ROUSSARD founded?
DR. BART ROUSSARD was founded on 06-06-2002.
Is DR. BART ROUSSARD still active?
Yes, DR. BART ROUSSARD is an active enterprise in the KBO register.
What is the turnover of DR. BART ROUSSARD?
The turnover in financial year 2025 is about €530,000. This figure is estimated from the gross margin of €349,473 and 31 comparable companies (NACE 86220). It probably lies between €470,000 and €730,000.Financials
Is DR. BART ROUSSARD profitable?
In financial year 2025, DR. BART ROUSSARD made a profit of €213,442.
Where can I find the annual accounts of DR. BART ROUSSARD?
DR. BART ROUSSARD filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. BART ROUSSARD due?
DR. BART ROUSSARD must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.